Simplex Trading’s Calliditas Therapeutics AB American Depositary Shares CALT Stock Holding History

Simplex Trading’s Portfolio CALT Stock Details CALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,826	Closed	–	–	9959
2024 Q3	$0	Buy	+1,826	New	+$72K	﹤0.01%	9856
2024 Q2	–	Sell	-671	Closed	-$18.4K	–	10090
2024 Q1	$14K	Buy	671 +347	+107%	+$7.72K	﹤0.01%	7397
2023 Q4	$8K	Sell	324 -212	-40%	-$3.97K	﹤0.01%	7617
2023 Q3	$9K	Sell	536 -603	-53%	-$10.4K	﹤0.01%	7291
2023 Q2	$18K	Buy	+1,139	New	+$24K	﹤0.01%	6905
2023 Q1	–	Sell	-185	Closed	-$3.7K	–	10399
2022 Q4	$3K	Sell	185 -105	-36%	-$1.69K	﹤0.01%	8462
2022 Q3	$4K	Buy	290 +289	+28,900%	+$5.03K	﹤0.01%	8998
2022 Q2	$0	Buy	+1	New	+$17	﹤0.01%	11381
2022 Q1	–	Sell	-1,184	Closed	-$29K	–	11623
2021 Q4	$29K	Buy	+1,184	New	+$23.8K	﹤0.01%	7966

Simplex Trading's CALT Position: Q4 2024 in Review

Simplex Trading sold out of Calliditas Therapeutics AB American Depositary Shares (CALT) in Q4 2024, closing a stake of 1,826 shares.

Simplex Trading first reported a position in CALT in Q4 2021 and held it in 9 quarters. The position peaked at $29K in Q4 2021. 0 funds tracked by Wall St. Rank hold CALT as of Q4 2024.

Simplex Trading reported no remaining Calliditas Therapeutics AB American Depositary Shares position as of Q4 2024 after selling out during the quarter.
Simplex Trading sold 1,826 Calliditas Therapeutics AB American Depositary Shares shares in Q4 2024.
Simplex Trading first reported a position in Calliditas Therapeutics AB American Depositary Shares in Q4 2021 and held it in 9 quarters.
Simplex Trading's Calliditas Therapeutics AB American Depositary Shares position peaked at $29K in Q4 2021.
0 funds tracked by Wall St. Rank held Calliditas Therapeutics AB American Depositary Shares as of Q4 2024.

Based on Simplex Trading's 13F filing for Q4 2024, filed 11 Feb 2025.